Weight loss and gout treatment for adults with obesity
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new medication, mazdutide, that may help with both weight loss and managing gout flares. If you are an adult with obesity and have had recent gout attacks, this study could offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is 30 or higher, which is considered obesity.
- You have been diagnosed with gout and have had at least 2 gout flares in the last 6 months.
- You have been on a stable dose of urate-lowering medication (like allopurinol or febuxostat) for at least 8 weeks, or you have stopped such medication in that time.
- Your weight has been stable (not changed more than 5%) in the last 6 months, with only diet and exercise.
- You have received gout management education or healthy lifestyle guidance for at least 6 months.
- You agree to maintain your current lifestyle and avoid significant changes during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the weight-loss drug orlistat, along with weight management, helps lower uric acid levels in people who have both gout and obesity. If you qualify, you may receive orlistat or a placebo to see if it reduces gout flare-ups and improves your uric acid control.
This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This trial tests a new drug called dotinurad for gout patients whose standard medications either don't work or cause side effects. Dotinurad works differently by helping your body get rid of uric acid (the substance that causes gout attacks), and the study will see if it safely lowers uric acid levels.
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
This study tests whether mazdutide, a medicine that may help with weight and blood sugar, can reduce plaque buildup in the heart's arteries. It is for people who are overweight or obese and have some narrowing in their heart arteries but do not need immediate procedures like stents.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.